Showing results (801-810 of 1,333) with videos related to

Sort By:
Pageof 134
Human Genetics|January 1, 1982
The Clinical Lipid Research Clinic Family Study: familial determinants of plasma uric acidD C Rao, P M Laskarzewski, J A Morrison, et al.
JAMA|January 14, 2000
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimensD V Havlir, N S Hellmann, C J Petropoulos, et al.
Annals of Clinical and Translational Neurology|July 4, 2020
Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIVRonald J Ellis, Monica Diaz, Ned Sacktor, et al.
HIV Clinical Trials|December 17, 2013
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202Philip M Grant, Camlin Tierney, Chakra Budhathoki, et al.
Insects|December 23, 2020
Evidence for Divergent Selection on Immune Genes between the African Malaria Vectors, Anopheles coluzzii and A. gambiaeYoosook Lee, Lattha Souvannaseng, Travis C Collier, et al.
Journal of Pharmaceutical Sciences|February 2, 2020
Integration of Computational and Experimental Approaches to Elucidate Mechanisms of First-Pass Lymphatic Drug Sequestration and Long-Acting Pharmacokinetics of the Injectable Triple-HIV Drug Combination TLC-ART 101Simone Perazzolo, Laura M Shireman, Lisa A McConnachie, et al.
The Journal of Infectious Diseases|November 14, 2012
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease statusKatie Mollan, Eric S Daar, Paul E Sax, et al.
Journal of Acquired Immune Deficiency Syndromes|January 11, 1992
Central nervous system manifestations in human immunodeficiency virus infection without AIDSA C Collier, C Marra, R W Coombs, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2014
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202Charles S Venuto, Katie Mollan, Qing Ma, et al.
Annals of Internal Medicine|January 1, 1995
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials GroupM A Fischl, K Stanley, A C Collier, et al.
Pageof 134